Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA-IN study of aspirin versus aspirin-free management in chronic coronary syndromes without revascularization
jRCT1051220039Recruiting
- Sponsor
- Daiichi Sankyo Healthcare
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Daiichi Sankyo Healthcare. Primary endpoint: Primary composite endpoint. Started Jun 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on jRCT1051220039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220039.